Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to demonstrate the relative bioavailability of 2 newly developed
fixed dose combination (FDC) tablets containing linagliptin & metformin and the single
tablets of linagliptin and metformin when administered singularly.